SomaLogic, Inc. (NASDAQ:SLGC) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET

Company Participants

Marissa Bych - IR, Gilmartin Group LLC

Roy Smythe - CEO

Shaun Blakeman - CFO

Stephen Williams - CMO

Conference Call Participants

Brandon Couillard - Jefferies

Daniel Brennan - Cowen

Kyle Mikson - Canaccord

Dan Arias - Stifel

Operator

Good day ladies and gentlemen, and thank you for standing by. Welcome to the SomaLogic's First Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions]

At this time, I would now like to turn the conference over to Ms. Marissa Bych. Ma'am please begin.

Marissa Bych

Thank you. Today, SomaLogic released financial results for the quarter ended March 31, 2022. A copy of the press release is available on the company's website. Before we begin, I'd like to remind you that management will make forward-looking statements during this call within the meaning of federal securities laws, which are made pursuant to the Safe Harbor Provision of the Private Securities Litigation Reform Act of 1995.

Any statements contained in this call that relates to expectations or predictions of future events, results, or performance are forward-looking statements. All forward-looking statements, including without limitation, those relating to our market opportunity, gross margin, and future financial performance, protein content, and database growth, customer base, diagnostic pipeline, expectations for hiring, and growth in our organization are based upon our current estimates and various assumptions.

These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements.

Accordingly, you should not place undue reliance on these statements for a list and description of the risks and uncertainties associated with our business, please refer to the Risk Factors section of our Form 10-Q filed with the Securities and Exchange Commission -- excuse me, Form 10-K with the Securities and Exchange Commission in March 2022.

This conference call contains time-sensitive information and is actuate only as of the live broadcast today, May 12, 2022. SomaLogic disclaims any intention or obligation, except as required by law, to update or revise any financial projections or forward-looking statements, whether because of new information, future events, or otherwise.

And with that, I will turn the call over to Roy Smythe, Chief Executive Officer.

Roy Smythe